JUST IN: FG Receives 699,760 Doses of AstraZeneca COVID-19 Vaccine from UK

0
116
pharmacy

 

JUST IN: FG Receives 699,760 Doses of AstraZeneca COVID-19 Vaccine from UK
NPHCDA Executive Director, Faisal Shuaib, taking the delivery of the consignment

 

The Nigerian Government has just taken delivery of 699,760 doses of AstraZeneca COVID-19 Vaccine from the United Kingdom.

 

This was announced Tuesday on the official Facebook Page of the National Primary Health Care Development Agency (NPHCDA), as it encourages citizens to avail themselves of the opportunity.

 

The post reads:  “Nigeria has taken delivery of 699,760 doses of AstraZeneca vaccine donated by the UK Government. The vaccine will be deployed immediately to the states & administered as second dose to those who had earlier received only the first dose of the AZ vaccine”.

 

This comes as the Presidential Steering Committee on COVID-19, in collaboration with the Federal Ministry of Health & the NPHCDA, flagged-off the second phase of COVID-19 vaccination at the Federal Medical Centre, Jabi, Abuja, on Monday.

READ
Nigeria Records 663 New Cases Of COVID-19, Total Now 13464

 

The Executive Director of NPHCDA, Faisal Shuaib has stated that this second phase of vaccination will be targeted at those due for their second dose of the AstraZeneca vaccine.

 

He disclosed earlier on Monday that “We will also be receiving today 698,880 doses of the AstraZeneca vaccine, a donation from the UK Government through the COVAX facility.

 

“These doses will be targeted at those due for their second dose of the AstraZeneca vaccine. 

“In the next couple of weeks, we will be expecting up to 3.9 million doses of the AstraZeneca vaccines to complement what we already have and tomorrow ensure that we cover not only those who will be taking their second AstraZeneca vaccine but also for those who will want to take their first dose of the vaccine.

 

READ
Unilorin PANS Hosts PSN President at Freshers’ Orientation

“As a result of the leadership provided by the Presidential Steering Committee and the Federal Ministry of Health, NPHCDA in collaboration with our partners have mapped out the best strategies in targeting different segments of our populations because of the differences in vulnerability, age, and geographical constraints,” he said.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here